Copyright
©The Author(s) 2021.
World J Hepatol. Dec 27, 2021; 13(12): 2168-2178
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2168
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2168
Overall (n = 23) | ||
Age (median, IQR), n (%) | 60 | |
Male | 14 | 60.9 |
Caucasian | 15 | 65% |
Etiology of cirrhosis | ||
Alcohol (EtOH) | 3 | 13.0 |
Granulomatous hepatitis | 1 | 4.4 |
HBV | 1 | 4.4 |
HCV | 10 | 43.5 |
HCV, EtOH | 1 | 4.4 |
Nonalcoholic steatohepatitis | 6 | 26.1 |
Primary sclerosing cholangitis | 1 | 4.4 |
Liver biopsy | 10 | 43.5 |
Liver transplantation | 3 | 13.0 |
Portal hypertension on imaging | 17 | 73.9 |
TIPS | 2 | 8.7 |
Cirrhosis on CT/US | 23 | 100.0 |
History of connective tissue disease | 1 | 4.4 |
Dialysis | 2 | 8.7 |
Endoscopy suite, n (%) | ||
Reason for EGD | ||
Anemia | 1 | 4.4 |
GI Bleed | 4 | 17.4 |
Varices | 18 | 78.2 |
Anticoagulation | 0 | 0.0 |
Alcohol use in the past 15 d | 5 | 21.7 |
ASA in the past 15 d | 7 | 31.8 |
NSAIDS use in the past 15 d | 0 | 0.0 |
Plavix | 0 | 0.0 |
Beta blockers | 10 | 45.5 |
Labs within 3 mo Pre EGD1 | median | IQR |
Hemoglobin | 10.6 | 9.5–13.3 |
Mean corpuscular volume | 89.2 | 87.0–90.5 |
Platelet count | 126.5 | 68.0–152.0 |
INR | 1.1 | 1.1–1.2 |
Serum sodium | 139.0 | 137.0–142.0 |
Alanine aminotransferase | 30.0 | 25.0–54.0 |
Aspartate aminotransferase | 50.0 | 32.0–79.0 |
Total bilirubin | 1.6 | 1.2–2.6 |
Alkaline phosphatase | 108.0 | 85.0–134.0 |
Serum albumin | 3.2 | 2.4–3.4 |
Ferritin | 74.3 | 5.0–2458.0 |
Creatinine | 1.0 | 0.70–1.47 |
Labs within 4-8 wk after EGD1 | median | IQR |
Hemoglobin | 11.4 | 8.9–12.8 |
Mean corpuscular volume | 87.9 | 84.8–91.6 |
Platelet count | 117.0 | 63.0–166.0 |
INR | 1.2 | 1.1–1.3 |
Serum sodium | 140.0 | 137.0–142.0 |
Alanine aminotransferase | 31.0 | 21.0–42.0 |
Aspartate aminotransferase | 44.0 | 29.0–68.0 |
Total bilirubin | 1.2 | 0.9–1.9 |
Alkaline phosphatase | 132.0 | 79.0–185.0 |
Serum albumin | 3.0 | 2.6–3.3 |
Ferritin | 197.4 | 63.0–199.0 |
Creatinine | 1.0 | 0.70–1.50 |
Biopsy | ||||
No GAVE | GAVE | |||
White Light | No GAVE | 10 | 1 | Sensitivity: 85.7% |
GAVE | 6 | 6 | Specificity: 62.5% | |
I-Scan | No GAVE | 12 | 0 | Sensitivity: 100% |
GAVE | 4 | 7 | Specificity: 75.0% |
Biopsy | ||||
No PHG | PHG | |||
White Light | No PHG | 4 | 1 | Sensitivity: 93.8% |
PHG | 3 | 15 | Specificity: 57.1% | |
I-Scan | No PHG | 5 | 2 | Sensitivity: 87.5% |
PHG | 2 | 14 | Specificity: 71.4% |
- Citation: Al-Taee AM, Cubillan MP, Hinton A, Sobotka LA, Befeler AS, Hachem CY, Hussan H. Accuracy of virtual chromoendoscopy in differentiating gastric antral vascular ectasia from portal hypertensive gastropathy: A proof of concept study. World J Hepatol 2021; 13(12): 2168-2178
- URL: https://www.wjgnet.com/1948-5182/full/v13/i12/2168.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i12.2168